|
DFTX Definium Therapeutics Inc 1813814 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-158,986,000.00 |
| Balance Sheet |
|
Current Assets
|
$1,092,101,000.00 |
|
Assets
|
$1,112,899,000.00 |
|
Current Liabilities
|
$157,204,000.00 |
|
Liabilities
|
$194,220,000.00 |
|
Equity
|
$918,679,000.00 |
|
Shares Out
|
134365950.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-95,409,000.00 |
|
Investing Cash Flow
|
$-274,738,000.00 |
| Market Analysis |
Market Cap
|
$6,100,214,130.00 |
|
Price
|
$45.40 |
|
BVPS
|
6.84 |
|
PB
|
6.64 |
|
EPS
|
-1.44 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:28 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:19 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-2.06 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-0.71 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DFTX documents filed with the SEC.
DFTX Filings
Clear
